The James Cook University Hospital is a major tertiary referral hospital, district general hospital and major trauma centre in Middlesbrough, North Yorkshire, England located on the A172.

There are 1,024 beds in James Cook University Hospital.

During the past decade, James Cook University Hospital conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 27 clinical trials were completed, i.e. on average, 36.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James Cook University Hospital" #1 sponsor was "University College, London" with 10 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored and "Boston Scientific Corporation" with 5 trials sponsored. Other sponsors include 126 different institutions and companies that sponsored additional 97 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James Cook University Hospital" #1 collaborator was "Cancer Research UK" with 12 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator and "London School of Hygiene and Tropical Medicine" with 3 trials as a collaborator. Other collaborators include 140 different institutions and companies that were collaborators in the rest 131 trials.

According to Clinical.Site data, the most researched conditions in "James Cook University Hospital" are "Breast Cancer" (6 trials), "Ovarian Cancer" (6 trials), "Colorectal Cancer" (5 trials), "Fallopian Tube Cancer" (5 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "James Cook University Hospital" in a lesser frequency.

Most popular intervention types in "James Cook University Hospital" are "Drug" (85 trials), "Procedure" (37 trials), "Device" (34 trials), "Other" (23 trials) and "Biological" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "adjuvant therapy" (7 trials), "quality-of-life assessment" (7 trials), "radiation therapy" (7 trials) and "Radiotherapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "James Cook University Hospital" are 143 trials for "All" genders, 17 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "James Cook University Hospital". undefined are not yet recruiting, 25 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in James Cook University Hospital, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in James Cook University Hospital, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 38 trials that are defined as “Not Applicable".